A Study Evaluating the Effects of CLAG With Gleevec in Refractory or Relapsed Acute Myeloid Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Clofarabine, Cytarabine, and Thymoglobulin for Allogeneic Transplantation
- Status
- TERMINATED
- Phase
- PHASE2
Phase 2 Haplotype Mismatched HSCT in Patients With Hematological Malignancies
- Status
- TERMINATED
- Phase
- PHASE2
Adding Lomustine to Chemotherapy in Older Patients With Acute Myelogenous Leukemia (AML), and Allogeneic Transplantation for Patients From 60 to 65 Years Old
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
- Status
- COMPLETED
- Phase
- PHASE2
Dose Escalation Phase I/II Study of Lovastatin With High-Dose Cytarabine for Refractory or Relapsed AML
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Combination of GTI-2040 and Cytarabine in the Treatment of Refractory and Relapsed Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE2
FLAG+Ida With G-CSF Priming for Patients Younger Than 60 Years With Resistant AML
- Status
- UNKNOWN
- Phase
- PHASE2
Phase I-II Study of Idarubicin, Cytarabine, and Sorafenib (BAY43-9006)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Tolerability Study of Voreloxin and Cytarabine Combination in Acute Myeloid Leukemia in Humans
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Transplantation of Umbilical Cord Blood Following Chemotherapy for Blood Cancers
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase I Epigenetic Priming Using Decitabine With Induction Chemotherapy in AML
- Status
- COMPLETED
- Phase
- PHASE1
Fludarabine and Cytarabine as Continuous Infusion Plus G-CSF Priming for Elderly Patients With Resistant AML
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Lintuzumab (SGN-33) in Combination With Low Dose Cytarabine in Patients 60+ Years With AML
- Status
- COMPLETED
- Phase
- PHASE2
Study to Assess the Safety of Escalating Doses of AT9283, in Patients With Leukemias
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Pilot Study of Umbilical Cord Blood Transplantation in Adult Patient With Advanced Hematopoietic Malignancies
- Status
- TERMINATED
- Phase
- NA
Pilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic Malignancies
- Status
- TERMINATED
- Phase
- N/A
Cytarabine in Combination With Arsenic Trioxide vs. Cytarabine Alone in Elderly Patients With Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE3
Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia
- Status
- COMPLETED
- Phase
- N/A
Study to Assess the Safety, Tolerability, and Efficacy of Tipifarnib Plus Bortezomib in the Treatment of Acute Myeloid Leukemia
- Status
- UNKNOWN
- Phase
- PHASE2